<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">JHEP Rep</span><span class="iso-abbrev" title="iso-abbrev">JHEP Rep</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">JHEP Reports</span></div><span class="issn-epub" tagx="issn" title="issn-epub">2589-5559</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">Elsevier</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7128473">7128473</a></span><span class="publisher-id" title="publisher-id">S2589-5559(20)30047-1</span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1016/j.jhepr.2020.100113">10.1016/j.jhepr.2020.100113</a></span><span class="publisher-id" title="publisher-id">100113</span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Review</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Boettler</span><span class="given-names" tagx="given-names" title="given-names">Tobias</span></span><a href="#aff1">1</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Newsome</span><span class="given-names" tagx="given-names" title="given-names">Philip N.</span></span><a href="#aff2">2</a><a href="#aff3">3</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mondelli</span><span class="given-names" tagx="given-names" title="given-names">Mario U.</span></span><a href="#aff4">4</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Maticic</span><span class="given-names" tagx="given-names" title="given-names">Mojca</span></span><a href="#aff5">5</a><a href="#aff6">6</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cordero</span><span class="given-names" tagx="given-names" title="given-names">Elisa</span></span><a href="#aff7">7</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cornberg</span><span class="given-names" tagx="given-names" title="given-names">Markus</span></span><a href="#aff8">8</a><a href="#aff9">9</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Berg</span><span class="given-names" tagx="given-names" title="given-names">Thomas</span></span><span class="email" tagx="email" title="email">Thomas.Berg@medizin.uni-leipzig.de</span><a href="#aff10">10</a><a href="#cor1">∗</a></span></div><span class="citation_author_institution" id="aff1">[1], </span><span class="citation_author_institution" id="aff2">[2], </span><span class="citation_author_institution" id="aff3">[3], </span><span class="citation_author_institution" id="aff4">[4], </span><span class="citation_author_institution" id="aff5">[5], </span><span class="citation_author_institution" id="aff6">[6], </span><span class="citation_author_institution" id="aff7">[7], </span><span class="citation_author_institution" id="aff8">[8], </span><span class="citation_author_institution" id="aff9">[9], </span><span class="citation_author_institution" id="aff10">[10], </span><div class="author-notes" title="author-notes"> <div class="corresp" title="corresp"><span class="label" tagx="label" title="label">∗</span>Corresponding author. Address: University Hospital Leipzig, Department of Internal Medicine, Liebigstraße 18, D-04103 Leipzig, Germany; Tel.: +49 341/97-12200, fax: +49 341/97-12209. <span class="email" tagx="email" title="email">Thomas.Berg@medizin.uni-leipzig.de</span></div> </div><span class="pub-date-pmc-release" title="pub-date-pmc-release">pmc-release: <span>2020-4-4</span></span><span class="pub-date-collection" title="pub-date-collection">collection: <span>2020-6</span></span><span class="pub-date-epub" title="pub-date-epub">epub: <span>2020-4-4</span></span><span class="volume" tagx="volume" title="volume">2</span><span class="issue" tagx="issue" title="issue">3</span><span class="elocation-id" tagx="elocation-id" title="elocation-id">100113</span><span class="history" title="history"><span class="received" title="received">received: 2020-3-25</span><span class="rev-recd" title="rev-recd">rev-recd: 2020-3-31</span><span class="accepted" title="accepted">accepted: 2020-3-31</span></span><div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder" />, <span class="copyright-year" tagx="copyright-year" title="copyright-year">2020</span></span><span class="license" title="license"><span class="license-p" title="license-p">This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</span></span></div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="title" tagx="title" title="title">
Summary</div> <p>The coronavirus disease 2019 (COVID-19) pandemic poses an enormous challenge to healthcare systems in affected communities. Older patients and those with pre-existing medical conditions have been identified as populations at risk of a severe disease course. It remains unclear at this point to what extent chronic liver diseases should be considered as risk factors, due to a shortage of appropriate studies. However, patients with advanced liver disease and those after liver transplantation represent vulnerable patient cohorts with an increased risk of infection and/or a severe course of COVID-19. In addition, the current pandemic requires unusual allocation of healthcare resources which may negatively impact the care of patients with chronic liver disease that continue to require medical attention. Thus, the challenge hepatologists are facing is to promote telemedicine in the outpatient setting, prioritise outpatient contacts, avoid nosocomial dissemination of the virus to patients and healthcare providers, and at the same time maintain standard care for patients who require immediate medical attention.</p> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Abbreviations</div> <div class="kwd" title="kwd">
ACE2, angiotensin-converting enzyme 2</div> <div class="kwd" title="kwd">
ACE-I, angiotensin-converting enzyme inhibitor</div> <div class="kwd" title="kwd">
ACLF, acute-on-chronic liver failure</div> <div class="kwd" title="kwd">
ALT, alanine aminotransferase</div> <div class="kwd" title="kwd">
AST, aspartate aminotransferase</div> <div class="kwd" title="kwd">
COVID-19, coronavirus disease 2019</div> <div class="kwd" title="kwd">
EGD, esophagogastroduodenoscopy</div> <div class="kwd" title="kwd">
ERC, endoscopic retrograde cholangiography</div> <div class="kwd" title="kwd">
HCC, hepatocellular carcinoma</div> <div class="kwd" title="kwd">
MELD, model for end-stage liver disease</div> <div class="kwd" title="kwd">
NAFLD, non-alcoholic fatty liver disease</div> <div class="kwd" title="kwd">
NASH, non-alcoholic steatohepatitis</div> <div class="kwd" title="kwd">
NUC, nucleoside analogue</div> <div class="kwd" title="kwd">
PIs, protease inhibitors</div> <div class="kwd" title="kwd">
RdRp, RNA-dependent RNA polymerase</div> <div class="kwd" title="kwd">
SARS-CoV-2, severe acute respiratory syndrome coronavirus 2</div> <div class="kwd" title="kwd">
ULN, upper limit of normal</div> </div> </div> </div> <div class="body" title="body"> <div class="introduction" title="sec"> <div class="title" tagx="title" title="title">
Introduction</div> <p id="p0010">Coronavirus disease 2019 (COVID-19) is caused by the recently identified coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Symptoms associated with COVID-19 are mostly fever, tiredness and dry cough. Some patients also develop symptoms including shortness of breath, aches, nasal congestion, sore throat, anosmia and ageusia. Nausea, vomiting and diarrhoea occur less frequently.<a href="#bib1"><sup>1</sup></a> While symptoms remain mild throughout the course of infection in the majority of patients, older patients were identified to be at higher risk of a fatal disease course, with hypertension, diabetes and coronary heart disease being the most frequent comorbidities in these cohorts.<a href="#bib2"><sup>2</sup></a><sup>,</sup><a href="#bib3"><sup>3</sup></a></p> </div> <div class="covid-19andtheliver" title="sec"> <div class="title" tagx="title" title="title">
COVID-19 and the liver</div> <p id="p0015">While pre-existing liver disease is not specifically listed in the published cohort studies, elevated alanine aminotransferase (ALT) levels, reduced platelet counts and reduced albumin levels at the time of admission have been associated with higher mortality,<a href="#bib2"><sup>2</sup></a> although not all of these alterations are independent risk factors. It remains unclear at this time whether these laboratory test alterations are a sign for pre-existing liver diseases in patients with a more severe course of infection, whether they rather reflect liver damage caused by the virus itself, or whether they mirror a severe inflammatory response (hypoalbuminemia) with disseminated intravascular coagulation (thrombocytopenia). Possibly, patients with advanced chronic liver disease are at increased risk of infection due to cirrhosis-associated immune dysfunction.<a href="#bib4"><sup>4</sup></a> The same could be true for patients after liver transplantation and possibly those with autoimmune liver diseases who receive immunosuppressive therapies.</p> <p id="p0020">However, currently, there are only limited data available linking underlying liver diseases with the course of SARS-CoV-2 infection and there are many open questions (<a href="#tbox1">Box 1</a>). Chronic hepatitis B virus infection for example, which is more prevalent in China than Europe, does not appear to affect the outcome of COVID-19.<a href="#bib1"><sup>1</sup></a> In addition, although there is no proof for this assumption, immunosuppression may even provide some protection from immunopathology, which appears to contribute to lung damage in cases with more severe manifestations of the disease.<a href="#bib5"><sup>5</sup></a><sup>,</sup><a href="#bib6"><sup>6</sup></a> These may be associated with a macrophage activation syndrome in the context of a hyperinflammatory syndrome characterised by a cytokine storm with multi-organ failure.<a href="#bib7"><sup>7</sup></a> On the other hand, systemic viral infections are often associated with transient elevations of transaminases which may reflect general immune activation or inflammation caused by circulating cytokines without compromising liver function, a phenomenon called "bystander hepatitis". This may also be the case in patients with COVID-19 where liver failure has not been specifically reported, even in the most severe and fatal courses of disease.<a href="#bib1"><sup>1</sup></a><sup>,</sup><a href="#bib2"><sup>2</sup></a> However, signs of liver dysfunction may occur in critically ill patients with COVID-19,<a href="#bib8"><sup>8</sup></a> as reviewed in.<a href="#bib9"><sup>9</sup></a><sup>,</sup><a href="#bib10"><sup>10</sup></a> Whether patients with cirrhosis and COVID-19 are at increased risk of decompensation or development of acute-on-chronic liver failure (ACLF), as has been shown for influenza infection,<a href="#bib11"><sup>11</sup></a> remains to be determined. SARS-CoV-2 may also directly infect liver cells as the receptor of the virus, angiotensin-converting enzyme 2 (ACE2),<a href="#bib12"><sup>12</sup></a> has been shown to be expressed on cholangiocytes,<a href="#bib13"><sup>13</sup></a><sup>,</sup><a href="#bib14"><sup>14</sup></a> which may explain cases of viral shedding into the faeces.<a href="#bib15"><sup>15</sup></a><sup>,</sup><a href="#bib16"><sup>16</sup></a> How far observations from Asian cohorts can be transferred to European populations remains to be determined, but it appears unlikely that SARS-CoV-2 infection causes liver damage to an amount that substantially contributes to the overall disease burden. </p><div class="boxed-text" tagx="boxed-text" title="boxed-text"><span class="label" tagx="label" title="label">Box 1</span> <div class="title" tagx="title" title="title">
Open questions for liver-related basic/translational research regarding COVID-19.</div>  <p id="p0695"> </p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/" /></div>  </div> ACLF, acute-on-chronic liver failure; COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.<p /> </div> <p /> <p id="p0025">Aside from the direct implications of liver disease on the course of COVID-19 or vice versa, there are several additional aspects that require attention. The current pandemic and the amount of available information – including misinformation and rumours – result in uncertainties and concerns among patients but also healthcare providers. While the threat that COVID-19 poses should not be underestimated, it remains important to maintain care of patients with chronic liver disease and to identify potential ways to prioritise care of these patients in times of limited healthcare resources.</p> </div> <div class="considerationsforpatientswithchronicliverdiseaseandpatientsafterlivertransplantation" title="sec"> <div class="title" tagx="title" title="title">
Considerations for patients with chronic liver disease and patients after liver transplantation</div> <p id="p0030">The recommendations provided here address the specific characteristics of patients with liver disease and are meant to provide additional guidance for the care of these patients. General recommendations and guidelines with regards to prevention, diagnosis and treatment of COVID-19 from local authorities should be adhered to.</p> </div> <div class="outpatientcare" title="sec"> <div class="title" tagx="title" title="title">
Outpatient care</div> <p id="p0035">The management and surveillance of patients with advanced liver disease and those receiving immunosuppressive treatment is often performed in larger units or centres. These institutions, however, are currently also COVID-19 hotspots, thus, potentially putting outpatients with chronic liver diseases at risk of nosocomial infections. In addition, hospital staffs face challenges such as long working hours and even reduced staffing because of COVID-19 quarantining. Therefore, several factors have to be considered by hepatologists who provide care for these vulnerable patients. Clearly, prioritisation criteria need to be defined for outpatient contacts. The general and specific recommendations provided here (<a href="#fig1">Fig. 1</a>) cannot comprehensively cover all patient cohorts and are not backed up by datasets. Moreover, the precise management of these patients strongly depends on the local COVID-19 burden. In case of COVID-19 in patients with more advanced chronic liver disease, we recommend admission for inpatient care depending on the presence of certain risk factors, which is discussed in more detail in a separate section. </p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 1</span></a></div>   <p>Flow chart for the prioritisation of patient care in patients with chronic liver disease.</p> <p>The individual management of these patients strongly depends on the local COVID-19 burden and officially implemented rules and regulations. In some countries and areas, maintenance of standard care might not be able and transplantation activities might be reduced. COVID-19, coronavirus disease 2019; HCC, hepatocellular carcinoma; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.</p>   </div> <p /> </div> <div class="reductionofdirectexposure" title="sec"> <div class="title" tagx="title" title="title">
Reduction of direct exposure</div> <p id="p0040">Physical distancing has been suggested and/or officially implemented in multiple countries across the globe to prevent dissemination of SARS-CoV-2. This measure aims to prevent a rapid increase in SARS-CoV-2 infections in the general population with the overall goal of minimising the number of patients with a severe course of COVID-19 at any one time, enabling healthcare providers to maintain medical/intensive care of these patients. At the same time, vulnerable patient cohorts should be protected from individuals with potential SARS-CoV-2 exposure or infection. Thus, in these patients, the benefits of maintaining patient care have to be weighed against the risk of infection. These considerations require adaption of standard operating procedures for outpatient care, including remodelling of waiting areas to allow sufficient distance between patients, reduction of waiting times and encouraging patients to wait outside wherever possible and eventually be contacted by phone. In addition, exposure to medical staff should be minimised wherever possible.</p> <p id="p0045">Face-to-face contact is the basis for the physician-patient relationships and allows physicians to quickly assess the overall condition of the patient. However, due to the amount of individual contacts, physicians are at risk of infection and subsequently also dissemination of the virus. Thus, it seems appropriate to also limit the amount of face-to-face contacts for patients at risk of a more severe course of infection. Technical solutions are available to enable remote physician-patient interactions and their benefits have already been discussed in the context of the COVID-19 pandemic.<a href="#bib17"><sup>17</sup></a> Health authorities should be urged to equip hospitals with such systems not only to attend to COVID-19 patients who stay in quarantine at home but also to care for patients that need to be protected from a potentially harmful infection and guide them through the pandemic, explaining the future treatment/management strategies/plan and provide advice concerning general prevention measures. The current pandemic clearly underlines the importance of making these technical solutions available to health care providers in order to be better prepared for situations like these in the future.</p> </div> <div class="patientswithcompensatedliverdisease" title="sec"> <div class="title" tagx="title" title="title">
Patients with compensated liver disease</div> <div class="generalconsiderations" title="sec"> <div class="title" tagx="title" title="title">
General considerations</div> <p id="p0050"> </p><ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0055">Visits to specialised centres can be postponed.</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0060">Use telemedicine or visits by phone wherever possible.</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0065">Routine laboratory testing can be performed locally, <i>e.g.</i> through primary care physician, and its frequency needs careful individual risk-benefit considerations.</p> </li> </ul> <p /> </div> <div class="specificconsiderations" title="sec"> <div class="title" tagx="title" title="title">
Specific considerations</div> <p id="p0070"> </p><ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0075">Chronic viral hepatitis does not appear to increase the risk of a severe course of COVID-19.<a href="#bib1"><sup>1</sup></a> Use telemedicine/local laboratory testing for follow-up visits in patients under antiviral therapy, send follow-up-prescriptions by mail.</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0080">Patients with non-alcoholic fatty liver disease (NAFLD) or steatohepatitis (NASH) may suffer from metabolic comorbidities such as diabetes, hypertension and obesity putting them at increased risk of a severe course of COVID-19.</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0085">In patients with autoimmune liver disease, we currently advise against reducing immunosuppressive therapy. Reductions should only be considered under special circumstances (<i>e.g.</i> medication-induced lymphopenia, or bacterial/fungal superinfection in case of severe COVID-19) after consultation of a specialist.</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0090">Emphasis on the importance of vaccination for <i>Streptococcus pneumoniae</i> and influenza.</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0095">In patients with compensated cirrhosis, consider delaying hepatocellular carcinoma (HCC) surveillance and screening for varices. Non-invasive risk assessment for the presence of varices should be applied for stratification (thrombocyte count or Baveno VI).<a href="#bib18"><sup>18</sup></a> See also section on "<a href="#sec10">liver-related diagnostic procedures</a>".</p> </li> </ul> <p /> </div> </div> <div class="patientswithdecompensatedliverdisease" title="sec"> <div class="title" tagx="title" title="title">
Patients with decompensated liver disease</div> <div class="generalconsiderations" title="sec"> <div class="title" tagx="title" title="title">
General considerations</div> <p id="p0100"> </p><ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0105">Care should be maintained according to guidelines but consider minimal exposure to medical staff, by using telemedicine/visits by phone wherever possible/required to avoid admission.</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0110">Listing for transplantation should be restricted to patients with poor short-term prognosis including those with acute/acute-on-chronic liver failure (ALF/ACLF), high model for end-stage liver disease (MELD) score (including exceptional MELDs) and HCC at the upper limits of the Milan criteria, as transplantation activities/organ donations will likely be reduced in many countries and areas.</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0115">Reducing the in-hospital liver transplant evaluation program to the strictly necessary is recommended to shorten the in-hospital stay and also reduce the number of consultations in other departments/clinics (<i>i.e.</i> ophthalmologic, dermatologic, dental, neurologic consultations can be done in local outpatient settings).</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0120">Emphasis on the importance of vaccination for <i>Streptococcus pneumoniae</i> and influenza.</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0125">Guidelines on prophylaxis of spontaneous bacterial peritonitis and hepatic encephalopathy should be closely followed to prevent decompensation and avoid admission.</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0130">Include testing for SARS-CoV-2 in patients with acute decompensation or ACLF.</p> </li> </ul> <p /> </div> <div class="specificconsiderationsforpatientsactivelylistedfortransplantation" title="sec"> <div class="title" tagx="title" title="title">
Specific considerations for patients actively listed for transplantation</div> <p id="p0135"> </p><ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0140">SARS-CoV-2 routine testing should be performed before transplantation in both donors and recipients, acknowledging that negative testing cannot completely rule out infection.</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0145">Consent for diagnostic and therapeutic procedures related to transplantation should include the potential risk of nosocomial COVID-19.</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0150">Living-donor transplantations should be considered on a case-by-case basis.</p> </li> </ul> <p /> </div> </div> <div class="patientswithhepatocellularcarcinoma" title="sec"> <div class="title" tagx="title" title="title">
Patients with hepatocellular carcinoma</div> <p id="p0155"> </p><ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0160">Care should be maintained according to guidelines including continuing systemic treatments and evaluation for liver transplantation, but consider minimal exposure to medical staff, by using telemedicine/visits by phone wherever possible/required to avoid admission.</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0165">In case of COVID-19, early admission is recommended. See also section on "<a href="#sec12">inpatient care</a>".</p> </li> </ul> <p /> </div> <div class="patientsafterlivertransplantation" title="sec"> <div class="title" tagx="title" title="title">
Patients after liver transplantation</div> <p id="p0170"> </p><ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0175">Maintain care according to guidelines, but consider minimal exposure to medical staff, by using telemedicine/visits by phone wherever possible/required to avoid admission.</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0180">Emphasis on the importance of vaccination for <i>Streptococcus pneumoniae</i> and influenza.</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0185">In stable patients: perform local laboratory testing (including drug levels).</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0190">We currently advise against reduction of immunosuppressive therapy. Reduction should only be considered under special circumstances (<i>e.g.</i> medication-induced lymphopenia, or bacterial/fungal superinfection in case of severe COVID-19) after consultation of a specialist.<a href="#bib19"><sup>19</sup></a></p> </li> </ul> <p /> </div> <div class="liver-relateddiagnosticprocedures" title="sec"> <div class="title" tagx="title" title="title">
Liver-related diagnostic procedures</div> <div class="endoscopy" title="sec"> <div class="title" tagx="title" title="title">
Endoscopy</div> <p id="p0195"><i>Patients without COVID-19:</i> Depending on available resources, screening for varices by esophagogastroduodenoscopy (EGD) should be reserved for patients at risk of variceal bleeding, such as patients with a history of variceal bleeding or signs of significant portal hypertension (ascites, thrombocyte count &amp;lt;100,000/μl). Non-invasive risk assessment for the presence of varices should be applied for stratification (thrombocyte count or Baveno VI).</p> <p id="p0200">Endoscopic retrograde cholangiography (ERC) for dilatation or stent replacement in patients after liver transplantation or patients with primary sclerosing cholangitis should be performed after careful individual risk-benefit considerations, including risk for nosocomial SARS-CoV-2 infection depending on local COVID-19 burden.</p> <p id="p0205"><i>Patients with COVID-19:</i> Endoscopic procedures are associated with an increased risk of disseminating SARS-CoV-2. During EGD or ERC, spreading of virus-containing droplets can occur. In addition, shedding of the virus in the faeces increases the risk of dissemination during colonoscopy. Thus, indications for endoscopic procedures in patients with COVID-19 should be limited to emergencies such as gastrointestinal bleeding, bacterial cholangitis or other life-threatening conditions.</p> </div> <div class="ultrasound(hccsurveillance)" title="sec"> <div class="title" tagx="title" title="title">
Ultrasound (HCC surveillance)</div> <p id="p0210"><i>Patients without COVID-19:</i> HCC surveillance can be deferred based on available resources (including availability of therapeutic options in case of HCC diagnosis) at the centre and the individual risk assessment. Patients with increased risk, such as patients with elevated alpha-fetoprotein levels, advanced cirrhosis, chronic hepatitis B, NASH/diabetes <i>etc.</i>, may be prioritised if resources are limited.</p> <p id="p0215"><i>Patients with COVID-19:</i> HCC surveillance should be deferred until after recovery.</p> </div> <div class="liverbiopsy" title="sec"> <div class="title" tagx="title" title="title">
Liver biopsy</div> <p id="p0220"><i>Patients without COVID-19:</i> Recommendations strongly depend on the local COVID-19 burden and the individual indication for histological assessment.</p> <p id="p0225">Biopsy should be deferred in patients with </p><ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0230">NAFLD or chronic viral hepatitis (for grading/staging)</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0235">mildly elevated transaminases (<i>e.g.</i> ALT &amp;lt;3× the upper limit of normal [ULN]) of unknown aetiology</p> </li> </ul> <p /> <p id="p0240">Biopsy should be performed in patients with </p><ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0245">strongly elevated transaminases (<i>e.g.</i> ALT &amp;gt;5× ULN) of unknown aetiology (in case of suspected autoimmune liver disease, treatment without histological diagnosis can be considered based on individual risk-benefit considerations)</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0250">liver masses suspicious of malignancy</p> </li> </ul> <p /> <p id="p0255"><i>Patients with COVID-19:</i> Liver biopsy should be deferred in most patients as </p><ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0260">treatment/care for COVID-19 outweighs diagnosis of co-existing liver disease</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0265">systemic inflammation associated with COVID-19 will obscure aetiology-specific histologic characteristics</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0270">liver biopsy may represent a risk for viral transmission (although the virus has so far not been detected in liver tissue, the expression of its receptor on cholangiocytes suggests that the virus might be present in the liver as well).</p> </li> </ul> <p /> </div> </div> <div class="collaborationwithlocalhealthcareprovidersandprimarycarephysicians" title="sec"> <div class="title" tagx="title" title="title">
Collaboration with local health care providers and primary care physicians</div> <p id="p0275">The necessity to reduce travel and limit visits to specialised centres is a challenge for liver disease patients and local health care providers alike. In order to facilitate decentralised care for these patients, close collaborations between specialised hepatologists and local health care providers is required. This pertains to several factors such as communication of immunosuppressive target levels in patients after liver transplantation, management of patients with severe ALT elevations of unknown aetiologies and others. Thus, we recommend that specialised centres provide easily accessible contact information for local health care providers to facilitate fast and uncomplicated collaboration for the benefit of patients with liver diseases.</p> </div> <div class="inpatientcare" title="sec"> <div class="title" tagx="title" title="title">
Inpatient care</div> <p id="p0280">Many patients with chronic liver disease will continue to require inpatient care during the COVID-19 crisis for decompensation, cholangitis, rejection or other complications. General measures to prevent SARS-CoV-2 exposure and infection will be of utmost importance for these patients. Depending on the local infrastructure, implementation of COVID-19-clean wards or hospitals is warranted. However, based on the local COVID-19-burden, a sharp separation of "clean" and "dirty" wards/hospitals may not be sustainable, although recent evidence provides somewhat reassuring data regarding the absence of environmental contamination with SARS-CoV-2 RNA of inanimate surfaces outside patient rooms.<a href="#bib20"><sup>20</sup></a> Wherever possible, patients with chronic liver disease requiring inpatient care for non-COVID-19 causes should be admitted to COVID-19-clean wards or hospitals. As these institutions may not be able to provide specialised hepatology-care, similar to our recommendations on outpatient care, we recommend that specialised centres provide easily accessible contact information to facilitate immediate hepatology consultations.</p> <p id="p0285">However, due to the contagiousness of the virus, patients with underlying liver disease will become infected and will subsequently require inpatient care for COVID-19. With regards to nosocomial-infections, recent observations from Spain that compared patient characteristics between patients with community-acquired influenza and nosocomial-acquired influenza could not detect a significant difference between these cohorts with regards to underlying chronic liver disease.<a href="#bib21"><sup>21</sup></a> Whether these observations will also hold up in the context of the COVID-19 pandemic remains to be proven. Until further evidence emerges, we recommend that patients with chronic liver disease and COVID-19 are admitted for inpatient care if they have additional risk factors for a more severe COVID-19 course like hypertension, diabetes or obesity, cirrhosis, HCC or a post-transplant status.</p> </div> <div class="treatmentconsiderationsforcovid-19" title="sec"> <div class="title" tagx="title" title="title">
Treatment considerations for COVID-19</div> <p id="p0290">Although there are currently no drugs approved for SARS-CoV-2, several repurposed drugs have been tested in recent weeks and many of them are still under investigation (see <a href="#tbl1">Table 1</a>).<a href="#bib22"><sup>22</sup></a> Remdesivir acts as an adenosine-analogue that induces RNA chain termination and was initially developed as an antiviral agent against Ebola.<a href="#bib23"><sup>23</sup></a> It has recently been shown to inhibit a clinical isolate of SARS-CoV-2 <i>in vitro</i><a href="#bib24"><sup>24</sup></a> and to reduce disease severity of the related MERS-CoV-infection in a non-human primate model <i>in vivo</i>.<a href="#bib25"><sup>25</sup></a> In addition, several reports have suggested clinical efficacy in patients suffering from COVID-19.<a href="#bib26"><sup>26</sup></a><sup>,</sup><a href="#bib27"><sup>27</sup></a> Clinical trials are ongoing to further evaluate efficacy in affected patients. Although ritonavir-boosted lopinavir showed some antiviral effect on SARS-CoV-2 <i>in vitro</i>, a recently published clinical trial in patients with severe COVID-19 showed no effect <i>in vivo</i> compared to no treatment.<a href="#bib28"><sup>28</sup></a> Other drugs currently under evaluation include chloroquine phosphate or hydroxychloroquine.<a href="#bib29"><sup>29</sup></a> Chloroquine has shown antiviral efficacy against SARS-CoV-2 <i>in vitro</i> through interference with the ACE2-receptor mediated endocytosis and is widely used in the treatment of patients with severe COVID-19 as monotherapy, but also in combination with azithromycin.<a href="#bib24"><sup>24</sup></a><sup>,</sup><a href="#bib30">[30]</a>, <a href="#bib31">[31]</a>, <a href="#bib32">[32]</a> The administration of any of these compounds to infected patients will remain an individual decision as efficacy and optimal timing remain to be clarified. However, with regards to patients with chronic liver disease, possible adverse events have to be kept in mind. This is particularly important with respect to drug-interactions in patients with certain immunosuppressive therapies where drug levels of cyclosporine, tacrolimus, sirolimus or everolimus will have to be closely monitored. In addition, patients with impaired liver function are at high risk of drug toxicities, <i>i.e.</i> in patients with Child-Pugh B/C cirrhosis. <a href="#tbl1">Table 1</a> summarises some considerations with regards to potential toxicities in these patients. It is also important to stress that all the drugs currently under investigation are not approved for SARS-CoV-2. However, given that early initiation of antiviral therapy is known to blunt the course of influenza, it is reasonable to assume that early treatment initiation might also be beneficial to prevent severe pneumonia in COVID-19. Thus, in patients with liver disease and risk factors for a severe course of the disease, we recommend inclusion into early antiviral treatment programmes or clinical trials that might be active at different centres. <div class="table-wrap_UNKNOWN" position="float" id="tbl1"><span class="label" tagx="label" title="label">Table 1</span> </div></p><p>Selected repurposed drugs that have been suggested/discussed for the treatment of COVID-19 and considerations for patients with liver disease or after liver transplantation.</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th>Drug</th> <th>Mechanism of action, rationale for COVID-19</th> <th>Considerations for patients with liver diseases or after liver transplantation</th> </tr> </thead> <tbody> <tr> <td>Remdesivir</td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0365">NUC/viral RNA polymerase inhibitor (completed phase III for Ebola treatment)</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0370">Inhibits SARS-CoV-2 <i>in vitro</i><a href="#bib24"><sup>24</sup></a></p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0375">Case reports with COVID-19<a href="#bib26"><sup>26</sup></a></p> </li> </ul> </td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0380">No relevant drug-interactions expected<a href="#bib34"><sup>34</sup></a></p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0385">No experience in liver cirrhosis but a NUC might be safer than other drug classes based on experience with NUCs in chronic hepatitis B and C</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0390">Liver toxicity (↑ALT) possible</p> </li> </ul> </td> </tr> <tr> <td>Chloroquine/Hydroxychloroquine<a href="#bib35"><sup>35</sup></a> ± azithromycin</td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0395">Interference with the cellular receptor ACE2<a href="#bib24"><sup>24</sup></a></p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0400">Endosomal acidification fusion inhibitor</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0405">Generally used for treatment of malaria and amoebiasis</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0410"><i>In vitro</i> and <i>in vivo</i> data<a href="#bib32"><sup>32</sup></a><sup>,</sup><a href="#bib36"><sup>36</sup></a></p> </li> </ul> </td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0415">Exclude G6PD deficiency before application</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0420">Drug-interactions with immunosuppressive drugs: close monitoring of drug level is required for cyclosporine, tacrolimus, sirolimus, everolimus<a href="#bib34"><sup>34</sup></a></p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0425">Hydroxychloroquine therapy has not been associated with ALT abnormalities and is an extremely rare cause of clinically apparent acute liver injury (LiverTox).</p> </li> </ul> </td> </tr> <tr> <td>Lopinavir/ritonavir</td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0430">Lopinavir/ritonavir are approved PIs for HIV</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0435"><i>In vitro</i> data, experience in patients with SARS, case reports with COVID-19<a href="#bib37"><sup>37</sup></a></p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0440">No proven efficacy <i>in vivo</i> in severe COVID-19<a href="#bib28"><sup>28</sup></a></p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0445">Many centres have discontinued its use</p> </li> </ul> </td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0450">Known and well-studied drug-interactions with immunosuppressive drugs. mTOR inhibitors (sirolimus, everolimus) should not be co-administered, close monitoring of drug level are required for calcineurin-inhibitors (cyclosporin, tacrolimus)<a href="#bib34"><sup>34</sup></a></p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0455">Data for patients with liver cirrhosis exist<a href="#bib38"><sup>38</sup></a></p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0460">The risk of lopinavir-associated hepatotoxicity in patients with very advanced liver disease is low</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0465">Based on experience with PIs in HCV, patients with decompensated cirrhosis should not be treated</p> </li> </ul> </td> </tr> <tr> <td>Tocilizumab</td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0470">Humanised mAb targeting interleukin-6 receptor</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0475">Treat cytokine release syndrome observed in COVID-19<a href="#bib7"><sup>7</sup></a></p> </li> </ul> </td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0480">ALT elevations are frequent but clinically apparent liver injury with jaundice seem to be rare<a href="#bib39"><sup>39</sup></a></p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0485">Patients with decompensated cirrhosis should not be treated</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0490">Consider risk of HBV reactivation<a href="#bib40"><sup>40</sup></a></p> </li> </ul> </td> </tr> <tr> <td>Methylprednisolone (steroids)</td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0495">Corticosteroids bind nuclear receptors to dampen proinflammatory cytokines</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0500">Mostly used in patients with septic shock</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0505">Currently NOT recommended by WHO<a href="#bib41"><sup>41</sup></a></p> </li> </ul> </td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0510">The risk of other infections (<i>e.g.</i> SBP) and viral shedding may increase in patents with decompensated liver cirrhosis</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0515">Consider antimicrobial prophylaxis</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0520">Consider risk of HBV reactivation</p> </li> </ul> </td> </tr> <tr> <td>Convalescent plasma</td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0525">Case reports with COVID-19<a href="#bib42"><sup>42</sup></a></p> </li> </ul> </td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0530">No experience in patients with chronic liver disease</p> </li> </ul> </td> </tr> <tr> <td>Umifenovir (Arbidol)<a href="#tbl1fnlowast">∗</a></td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0535">May inhibit viral entry into target cells and stimulate the immune response, used to treat influenza in some countries<a href="#bib31"><sup>31</sup></a></p> </li> </ul> </td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0540">Possible drug interactions between arbidol and CYP3A4 inhibitors and inducers<a href="#bib43"><sup>43</sup></a></p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0545">Potentially metabolised in liver and intestines in humans. Caution in patients with liver cirrhosis</p> </li> </ul> </td> </tr> <tr> <td>Favipiravir/favilavir<a href="#tbl1fnlowast">∗</a></td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0550">Guanine analogue, RNA-dependent RNA polymerase (RdRp)- inhibitor, approved for influenza in Japan</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0555">Preliminary results from a study with 80 COVID-19 patients<a href="#bib31"><sup>31</sup></a></p> </li> </ul> </td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0560">Metabolised by aldehyde oxidase and xanthine oxidase. CYP450 isoenzymes are not involved in the metabolism</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0565">Elevation of ALT and AST possible.</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0570">No data in cirrhosis available</p> </li> </ul> </td> </tr> <tr> <td>Sofosbuvir<a href="#tbl1fnlowast">∗</a><br /><br />maybe combination with ribavirin</td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0575">Nucleotide analogue, RdRp-inhibitor</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0580">Approved for treatment of chronic hepatitis C</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0585"><i>In vitro</i> data show binding to SARS-CoV-2 RdRp<a href="#bib44"><sup>44</sup></a></p> </li> </ul> </td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0590">Good experience in patients with chronic hepatitis C including patients with decompensated cirrhosis</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0595">For drug-interaction details see<a href="#bib45"><sup>45</sup></a></p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0600">Ribavirin may cause severe haemolytic anaemia</p> </li> </ul> </td> </tr> <tr> <td>Baricitinib<a href="#tbl1fnlowast">∗</a></td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0605">Janus kinase inhibitor, might interrupt endocytosis of the virus and intracellular assembly of virus particles<a href="#bib46"><sup>46</sup></a></p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0610">Could affect both inflammation and cellular viral entry</p> </li> </ul> </td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0615">Associated with transient and usually mild elevations of ALT<a href="#bib47"><sup>47</sup></a></p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0620">Patients with decompensated cirrhosis should not be treated</p> </li> </ul> </td> </tr> <tr> <td>Camostat<a href="#tbl1fnlowast">∗</a></td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0625">Blocks serine protease TMPRSS2 <i>in vitro</i> which is required for S protein priming<a href="#bib48"><sup>48</sup></a></p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0630">Licensed in Japan for treatment of chronic pancreatitis</p> </li> </ul> </td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0635">Patients with chronic viral hepatitis and cirrhosis are excluded from clinical trial for chronic pancreatitis.<a href="#bib49"><sup>49</sup></a></p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0640">Drug-interactions unknown</p> </li> </ul> </td> </tr> <tr> <td>Emapalumab<a href="#tbl1fnlowast">∗</a></td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0645">mAb targeting interferon-gamma</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0650">Treat cytokine release syndrome observed in COVID-19<a href="#bib7"><sup>7</sup></a></p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0655">Approved for haemophagocytic lymphohistiocytosis</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0660">Clinical trial for COVID-19 planned<a href="#bib50"><sup>50</sup></a></p> </li> </ul> </td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0665">Associated with mild and transient ALT elevations typically arising a few weeks after start of treatment</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0670">Risk of reactivation of tuberculosis, pneumocystis jirovecii, herpes zoster</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0675">Risk of HBV reactivation may be lower</p> </li> </ul> </td> </tr> <tr> <td>Anakinra<a href="#tbl1fnlowast">∗</a></td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0680">Interleukin 1 receptor antagonist</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0685">Clinical trial for COVID-19 planned<a href="#bib50"><sup>50</sup></a></p> </li> </ul> </td> <td> <ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0690">Minimal hepatic metabolism</p> </li> </ul> </td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>This list is not intended to give treatment recommendations. The evidence to use these drugs is low. Multiple RCTs for the above-mentioned drugs and some other drugs are ongoing in patients with SARS-CoV-2 infection.</p> </div> <div class="fn-type-" title=""> <p>ACE2, angiotensin-converting enzyme 2; ALT, alanine aminotransferase; AST, aspartate aminotransferase; COVID-19, coronavirus disease 2019; NUC, nucleoside analogue; PIs, protease inhibitors; RdRp, RNA-dependent RNA polymerase; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.</p> </div> </div> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">∗</span><p id="ntpara0010">These drugs are listed to include the most frequently discussed agents for COVID-19. These drugs may lack clinical efficacy, and some have been considered based on <i>in vitro</i> observations or their mode of action.</p> </div> </div>  <p /> <div class="generalconsiderationsforpatientswithchronicliverdiseaseandcovid-19" title="sec"> <div class="title" tagx="title" title="title">
General considerations for patients with chronic liver disease and COVID-19</div> <p id="p0295"> </p><ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0300">Consider early admission according to the presence of additional risk factors and inclusion in clinical trials and (experimental) antiviral therapy of COVID-19 following local guidelines (see <a href="#tbl1">Table 1</a> for guidance with regards to CLD)</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0305">Prevent acetaminophen overdosing (2–3 g/day is considered safe in patients with cirrhosis without active alcohol consumption<a href="#bib33"><sup>33</sup></a>)</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0310">Do not administer non-steroidal anti-inflammatory drugs in patients with cirrhosis and portal hypertension<a href="#bib33"><sup>33</sup></a></p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0315">See also section on "<a href="#sec10">liver-related diagnostic procedures</a>" for recommendations on endoscopy, HCC surveillance and liver biopsy</p> </li> </ul> <p /> </div> <div class="specificconsiderationsforpatientswithchronicliverdiseaseandcovid-19" title="sec"> <div class="title" tagx="title" title="title">
Specific considerations for patients with chronic liver disease and COVID-19</div> <p id="p0320"> </p><ul> <li><span class="label" tagx="label" title="label">•</span><p id="p0325">In patients with decompensated cirrhosis, treatment for cirrhosis-associated complications such as portal hypertension, ascites, hepatic encephalopathy, spontaneous bacterial peritonitis <i>etc.</i> should be continued.</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0330">In patients with HCC, locoregional therapies should be postponed whenever possible and immune-checkpoint inhibitor therapy temporarily withdrawn. The decision on whether to continue (reduced dose) kinase inhibitors in non-severe COVID-19 should be taken on a case-by-case basis.</p> </li> <li><span class="label" tagx="label" title="label">•</span><p id="p0335">In patients after liver transplantation, dose adjustment of calceurin- and/or mTOR- inhibitors might be required depending on the antiviral therapy initiated (<a href="#tbl1">Table 1</a>).</p> </li> </ul> <p /> </div> </div> <div class="COI-statement" title="COI-statement"> <div class="title" tagx="title" title="title">
Conflicts of interest</div> <p id="p0340">Dr Berg reports grants, personal fees and non-financial support from </p><div class="funding-source" title="funding-source">
Gilead</div>. Dr Boettler reports consultancy fees from Gilead. Dr Cornberg reports personal fees from Gilead. All other authors report no conflicts of interest.<p /> <p id="p0345">Please refer to the accompanying <a href="#appsec1">ICMJE disclosure</a> forms for further details.</p> </div> </div> <div class="back" title="back"> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="bib1" /><span class="label" tagx="label" title="label">1</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guan</span><span class="given-names" tagx="given-names" title="given-names">W.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ni</span><span class="given-names" tagx="given-names" title="given-names">Z.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liang</span><span class="given-names" tagx="given-names" title="given-names">W.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ou</span><span class="given-names" tagx="given-names" title="given-names">C.Q.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">He</span><span class="given-names" tagx="given-names" title="given-names">J.X.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical characteristics of coronavirus disease 2019 in China</span><span class="source" tagx="source" title="source">N Engl J Med</span><span class="year" tagx="year" title="year">2020</span><span class="comment">[Epub ahead of print]</span></span></li> <li tag="ref"><a name="bib2" /><span class="label" tagx="label" title="label">2</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Du</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fan</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study</span><span class="source" tagx="source" title="source">Lancet</span><span class="volume" tagx="volume" title="volume">395</span><span class="issue" tagx="issue" title="issue">10229</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1054</span><span class="lpage" tagx="lpage" title="lpage">1062</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32171076">32171076</a></span></span></li> <li tag="ref"><a name="bib3" /><span class="label" tagx="label" title="label">3</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zheng</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gou</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pu</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guo</span><span class="given-names" tagx="given-names" title="given-names">Q.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis</span><span class="source" tagx="source" title="source">Int J Infect Dis</span><span class="year" tagx="year" title="year">2020</span><span class="comment">[Epub ahead of print]</span></span></li> <li tag="ref"><a name="bib4" /><span class="label" tagx="label" title="label">4</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Albillos</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lario</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Álvarez-Mon</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance</span><span class="source" tagx="source" title="source">J Hepatol</span><span class="volume" tagx="volume" title="volume">61</span><span class="year" tagx="year" title="year">2014</span><span class="fpage" tagx="fpage" title="fpage">1385</span><span class="lpage" tagx="lpage" title="lpage">1396</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25135860">25135860</a></span></span></li> <li tag="ref"><a name="bib5" /><span class="label" tagx="label" title="label">5</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shi</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Pathological findings of COVID-19 associated with acute respiratory distress syndrome</span><span class="source" tagx="source" title="source">Lancet Respir Med</span><span class="year" tagx="year" title="year">2020</span><span class="comment">[Epub ahead of print]</span></span></li> <li tag="ref"><a name="bib6" /><span class="label" tagx="label" title="label">6</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Geng</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Peng</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Meng</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lu</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Molecular immune pathogenesis and diagnosis of COVID-19</span><span class="source" tagx="source" title="source">J Pharm Anal</span><span class="year" tagx="year" title="year">2020</span><span class="comment">[Epub ahead of print]</span></span></li> <li tag="ref"><a name="bib7" /><span class="label" tagx="label" title="label">7</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mehta</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">McAuley</span><span class="given-names" tagx="given-names" title="given-names">D.F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Brown</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sanchez</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tattersall</span><span class="given-names" tagx="given-names" title="given-names">R.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Manson</span><span class="given-names" tagx="given-names" title="given-names">J.J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">COVID-19: consider cytokine storm syndromes and immunosuppression</span><span class="source" tagx="source" title="source">Lancet</span><span class="volume" tagx="volume" title="volume">395</span><span class="issue" tagx="issue" title="issue">10229</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1033</span><span class="lpage" tagx="lpage" title="lpage">1034</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32192578">32192578</a></span></span></li> <li tag="ref"><a name="bib8" /><span class="label" tagx="label" title="label">8</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shu</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xia</span><span class="given-names" tagx="given-names" title="given-names">Ja</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study</span><span class="source" tagx="source" title="source">Lancet Respir Med</span><span class="year" tagx="year" title="year">2020</span><span class="comment">[Epub ahead of print]</span></span></li> <li tag="ref"><a name="bib9" /><span class="label" tagx="label" title="label">9</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shi</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">F.-S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Liver injury in COVID-19: management and challenges</span><span class="source" tagx="source" title="source">Lancet Gastroenterol Hepatol</span><span class="year" tagx="year" title="year">2020</span><span class="comment">[Epub ahead of print]</span></span></li> <li tag="ref"><a name="bib10" /><span class="label" tagx="label" title="label">10</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lu</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zheng</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Liver injury during highly pathogenic human coronavirus infections</span><span class="source" tagx="source" title="source">Liver Int</span><span class="year" tagx="year" title="year">2020</span><span class="comment">[Epub ahead of print]</span></span></li> <li tag="ref"><a name="bib11" /><span class="label" tagx="label" title="label">11</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schütte</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ciesek</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wedemeyer</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lange</span><span class="given-names" tagx="given-names" title="given-names">C.M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Influenza virus infection as precipitating event of acute-on-chronic liver failure</span><span class="source" tagx="source" title="source">J Hepatol</span><span class="volume" tagx="volume" title="volume">70</span><span class="year" tagx="year" title="year">2019</span><span class="fpage" tagx="fpage" title="fpage">797</span><span class="lpage" tagx="lpage" title="lpage">799</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30635243">30635243</a></span></span></li> <li tag="ref"><a name="bib12" /><span class="label" tagx="label" title="label">12</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Walls</span><span class="given-names" tagx="given-names" title="given-names">A.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Park</span><span class="given-names" tagx="given-names" title="given-names">Y.-J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tortorici</span><span class="given-names" tagx="given-names" title="given-names">M.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wall</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">McGuire</span><span class="given-names" tagx="given-names" title="given-names">A.T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Veesler</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein</span><span class="source" tagx="source" title="source">Cell</span><span class="year" tagx="year" title="year">2020</span><span class="comment">[Epub ahead of print]</span></span></li> <li tag="ref"><a name="bib13" /><span class="label" tagx="label" title="label">13</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chai</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Han</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lu</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ke</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection</span><span class="source" tagx="source" title="source">bioRxiv</span><span class="year" tagx="year" title="year">2020</span></span></li> <li tag="ref"><a name="bib14" /><span class="label" tagx="label" title="label">14</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhong</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Deng</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Peng</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dan</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zeng</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span></span><span class="mixed-article-title" title="mixed-article-title">High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa</span><span class="source" tagx="source" title="source">Int J Oral Sci</span><span class="volume" tagx="volume" title="volume">12</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">8</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32094336">32094336</a></span></span></li> <li tag="ref"><a name="bib15" /><span class="label" tagx="label" title="label">15</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yeo</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kaushal</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yeo</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?</span><span class="source" tagx="source" title="source">Lancet Gastroenterol Hepatol</span><span class="volume" tagx="volume" title="volume">5</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">335</span><span class="lpage" tagx="lpage" title="lpage">337</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32087098">32087098</a></span></span></li> <li tag="ref"><a name="bib16" /><span class="label" tagx="label" title="label">16</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Han</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">COVID-19: gastrointestinal manifestations and potential fecal-oral transmission</span><span class="source" tagx="source" title="source">Gastroenterology</span><span class="year" tagx="year" title="year">2020</span><span class="comment">[Epub ahead of print]</span></span></li> <li tag="ref"><a name="bib17" /><span class="label" tagx="label" title="label">17</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hollander</span><span class="given-names" tagx="given-names" title="given-names">J.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Carr</span><span class="given-names" tagx="given-names" title="given-names">B.G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Virtually perfect? Telemedicine for Covid-19</span><span class="source" tagx="source" title="source">N Engl J Med</span><span class="year" tagx="year" title="year">2020</span><span class="comment">[Epub ahead of print]</span></span></li> <li tag="ref"><a name="bib18" /><span class="label" tagx="label" title="label">18</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Maurice</span><span class="given-names" tagx="given-names" title="given-names">J.B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Brodkin</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Arnold</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Navaratnam</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Paine</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Khawar</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices</span><span class="source" tagx="source" title="source">J Hepatol</span><span class="volume" tagx="volume" title="volume">65</span><span class="year" tagx="year" title="year">2016</span><span class="fpage" tagx="fpage" title="fpage">899</span><span class="lpage" tagx="lpage" title="lpage">905</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27388923">27388923</a></span></span></li> <li tag="ref"><a name="bib19" /><span class="label" tagx="label" title="label">19</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhu</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ma</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guan</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression</span><span class="source" tagx="source" title="source">Am J Transplant</span><span class="year" tagx="year" title="year">2020</span><span class="comment">[Epub ahead of print]</span></span></li> <li tag="ref"><a name="bib20" /><span class="label" tagx="label" title="label">20</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Colaneri</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Seminari</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Piralla</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zuccaro</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Filippo</span><span class="given-names" tagx="given-names" title="given-names">A.D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baldanti</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy</span><span class="source" tagx="source" title="source">J Hosp Infect</span><span class="year" tagx="year" title="year">2020</span><span class="comment">[Epub ahead of print]</span></span></li> <li tag="ref"><a name="bib21" /><span class="label" tagx="label" title="label">21</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Godoy</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Torner</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Soldevila</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rius</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jane</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Martínez</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Hospital-acquired influenza infections detected by a surveillance system over six seasons, from 2010/2011 to 2015/2016</span><span class="source" tagx="source" title="source">BMC Infect Dis</span><span class="volume" tagx="volume" title="volume">20</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">80</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31992207">31992207</a></span></span></li> <li tag="ref"><a name="bib22" /><span class="label" tagx="label" title="label">22</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">Harrison C. Coronavirus puts drug repurposing on the fast track. 2020. Available from: <a href="https://www.nature.com/articles/d41587-020-00003-1">https://www.nature.com/articles/d41587-020-00003-1</a>. [Accessed 12 March 2020].</span></li> <li tag="ref"><a name="bib23" /><span class="label" tagx="label" title="label">23</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Warren</span><span class="given-names" tagx="given-names" title="given-names">T.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jordan</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lo</span><span class="given-names" tagx="given-names" title="given-names">M.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ray</span><span class="given-names" tagx="given-names" title="given-names">A.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mackman</span><span class="given-names" tagx="given-names" title="given-names">R.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Soloveva</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys</span><span class="source" tagx="source" title="source">Nature</span><span class="volume" tagx="volume" title="volume">531</span><span class="year" tagx="year" title="year">2016</span><span class="fpage" tagx="fpage" title="fpage">381</span><span class="lpage" tagx="lpage" title="lpage">385</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26934220">26934220</a></span></span></li> <li tag="ref"><a name="bib24" /><span class="label" tagx="label" title="label">24</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cao</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro</span><span class="source" tagx="source" title="source">Cell Res</span><span class="volume" tagx="volume" title="volume">30</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">269</span><span class="lpage" tagx="lpage" title="lpage">271</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32020029">32020029</a></span></span></li> <li tag="ref"><a name="bib25" /><span class="label" tagx="label" title="label">25</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">de Wit</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Feldmann</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cronin</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jordan</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Okumura</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Thomas</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection</span><span class="source" tagx="source" title="source">Proc Natl Acad Sci</span><span class="volume" tagx="volume" title="volume">117</span><span class="issue" tagx="issue" title="issue">12</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">6771</span><span class="lpage" tagx="lpage" title="lpage">6776</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32054787">32054787</a></span></span></li> <li tag="ref"><a name="bib26" /><span class="label" tagx="label" title="label">26</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Holshue</span><span class="given-names" tagx="given-names" title="given-names">M.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">DeBolt</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lindquist</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lofy</span><span class="given-names" tagx="given-names" title="given-names">K.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wiesman</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bruce</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">First case of 2019 novel coronavirus in the United States</span><span class="source" tagx="source" title="source">New Engl J Med</span><span class="volume" tagx="volume" title="volume">382</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">929</span><span class="lpage" tagx="lpage" title="lpage">936</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32004427">32004427</a></span></span></li> <li tag="ref"><a name="bib27" /><span class="label" tagx="label" title="label">27</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sheahan</span><span class="given-names" tagx="given-names" title="given-names">T.P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sims</span><span class="given-names" tagx="given-names" title="given-names">A.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Leist</span><span class="given-names" tagx="given-names" title="given-names">S.R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schäfer</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Won</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Brown</span><span class="given-names" tagx="given-names" title="given-names">A.J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV</span><span class="source" tagx="source" title="source">Nat Commun</span><span class="volume" tagx="volume" title="volume">11</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">222</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31924756">31924756</a></span></span></li> <li tag="ref"><a name="bib28" /><span class="label" tagx="label" title="label">28</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cao</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wen</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fan</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19</span><span class="source" tagx="source" title="source">N Engl J Med</span><span class="year" tagx="year" title="year">2020</span></span></li> <li tag="ref"><a name="bib29" /><span class="label" tagx="label" title="label">29</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gao</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tian</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies</span><span class="source" tagx="source" title="source">Biosci Trends</span><span class="volume" tagx="volume" title="volume">14</span><span class="issue" tagx="issue" title="issue">1</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">72</span><span class="lpage" tagx="lpage" title="lpage">73</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32074550">32074550</a></span></span></li> <li tag="ref"><a name="bib30" /><span class="label" tagx="label" title="label">30</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">De Clercq</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Therapeutic options for the 2019 novel coronavirus (2019-nCoV)</span><span class="source" tagx="source" title="source">Nat Rev Drug Discov</span><span class="volume" tagx="volume" title="volume">19</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">149</span><span class="lpage" tagx="lpage" title="lpage">150</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32127666">32127666</a></span></span></li> <li tag="ref"><a name="bib31" /><span class="label" tagx="label" title="label">31</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dong</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gao</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Discovering drugs to treat coronavirus disease 2019 (COVID-19)</span><span class="source" tagx="source" title="source">Drug Discoveries Ther</span><span class="volume" tagx="volume" title="volume">14</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">58</span><span class="lpage" tagx="lpage" title="lpage">60</span></span></li> <li tag="ref"><a name="bib32" /><span class="label" tagx="label" title="label">32</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gautret</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lagier</span><span class="given-names" tagx="given-names" title="given-names">J.-C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Parola</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hoang</span><span class="given-names" tagx="given-names" title="given-names">V.T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Meddeb</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mailhe</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial</span><span class="source" tagx="source" title="source">Int J Antimicrob Agents</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">105949</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32205204">32205204</a></span></span></li> <li tag="ref"><a name="bib33" /><span class="label" tagx="label" title="label">33</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chandok</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Watt</span><span class="given-names" tagx="given-names" title="given-names">K.D.S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Pain management in the cirrhotic patient: the clinical challenge</span><span class="source" tagx="source" title="source">Mayo Clinic Proc</span><span class="volume" tagx="volume" title="volume">85</span><span class="year" tagx="year" title="year">2010</span><span class="fpage" tagx="fpage" title="fpage">451</span><span class="lpage" tagx="lpage" title="lpage">458</span></span></li> <li tag="ref"><a name="bib34" /><span class="label" tagx="label" title="label">34</span><span class="element-citation'"><span class="source" tagx="source" title="source">COVID-19 Drug interactions</span><span class="year" tagx="year" title="year">2020</span><span class="comment">Available from:</span><a href="http://www.covid19-druginteractions.org/">http://www.covid19-druginteractions.org/</a></span></li> <li tag="ref"><a name="bib35" /><span class="label" tagx="label" title="label">35</span><span class="element-citation'"><span class="mixed-article-title" title="mixed-article-title">[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]</span><span class="source" tagx="source" title="source">Zhonghua Jie He He Hu Xi Za Z</span><span class="volume" tagx="volume" title="volume">43</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">E019</span></span></li> <li tag="ref"><a name="bib36" /><span class="label" tagx="label" title="label">36</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Al-Bari</span><span class="given-names" tagx="given-names" title="given-names">M.A.A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases</span><span class="source" tagx="source" title="source">Pharmacol Res Perspect</span><span class="volume" tagx="volume" title="volume">5</span><span class="year" tagx="year" title="year">2017</span><span class="fpage" tagx="fpage" title="fpage">e00293</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28596841">28596841</a></span></span></li> <li tag="ref"><a name="bib37" /><span class="label" tagx="label" title="label">37</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Young</span><span class="given-names" tagx="given-names" title="given-names">B.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ong</span><span class="given-names" tagx="given-names" title="given-names">S.W.X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kalimuddin</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Low</span><span class="given-names" tagx="given-names" title="given-names">J.G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tan</span><span class="given-names" tagx="given-names" title="given-names">S.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Loh</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore</span><span class="source" tagx="source" title="source">JAMA</span><span class="year" tagx="year" title="year">2020</span><span class="comment">[Epub ahead of print]</span></span></li> <li tag="ref"><a name="bib38" /><span class="label" tagx="label" title="label">38</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Casado</span><span class="given-names" tagx="given-names" title="given-names">J.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Del Palacio</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Moya</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rodriguez</span><span class="given-names" tagx="given-names" title="given-names">J.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Moreno</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Perez-Elías</span><span class="given-names" tagx="given-names" title="given-names">M.J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Safety and pharmacokinetics of lopinavir in HIV/HCV coinfected patients with advanced liver disease</span><span class="source" tagx="source" title="source">HIV Clin Trials</span><span class="volume" tagx="volume" title="volume">12</span><span class="year" tagx="year" title="year">2011</span><span class="fpage" tagx="fpage" title="fpage">235</span><span class="lpage" tagx="lpage" title="lpage">243</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22180521">22180521</a></span></span></li> <li tag="ref"><a name="bib39" /><span class="label" tagx="label" title="label">39</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Genovese</span><span class="given-names" tagx="given-names" title="given-names">M.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kremer</span><span class="given-names" tagx="given-names" title="given-names">J.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">van Vollenhoven</span><span class="given-names" tagx="given-names" title="given-names">R.F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Alten</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Scali</span><span class="given-names" tagx="given-names" title="given-names">J.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kelman</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Transaminase levels and hepatic events during tocilizumab treatment: pooled analysis of long-term clinical trial safety data in rheumatoid arthritis</span><span class="source" tagx="source" title="source">Arthritis Rheumatol</span><span class="volume" tagx="volume" title="volume">69</span><span class="year" tagx="year" title="year">2017</span><span class="fpage" tagx="fpage" title="fpage">1751</span><span class="lpage" tagx="lpage" title="lpage">1761</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28597609">28597609</a></span></span></li> <li tag="ref"><a name="bib40" /><span class="label" tagx="label" title="label">40</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">L.-F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mo</span><span class="given-names" tagx="given-names" title="given-names">Y.-Q.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jing</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ma</span><span class="given-names" tagx="given-names" title="given-names">J.-D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zheng</span><span class="given-names" tagx="given-names" title="given-names">D.-H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dai</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation</span><span class="source" tagx="source" title="source">Int J Rheum Dis</span><span class="volume" tagx="volume" title="volume">20</span><span class="year" tagx="year" title="year">2017</span><span class="fpage" tagx="fpage" title="fpage">859</span><span class="lpage" tagx="lpage" title="lpage">869</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28160426">28160426</a></span></span></li> <li tag="ref"><a name="bib41" /><span class="label" tagx="label" title="label">41</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">WHO. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. 2020. Available from: <a href="https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected">https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected</a>. [Accessed 18 March 2020].</span></li> <li tag="ref"><a name="bib42" /><span class="label" tagx="label" title="label">42</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shen</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yuan</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Treatment of 5 critically ill patients with COVID-19 with convalescent plasma</span><span class="source" tagx="source" title="source">JAMA</span><span class="year" tagx="year" title="year">2020</span></span></li> <li tag="ref"><a name="bib43" /><span class="label" tagx="label" title="label">43</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Deng</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhong</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Pharmacokinetics, metabolism, and excretion of the antiviral drug arbidol in humans</span><span class="source" tagx="source" title="source">Antimicrob Agents Chemother</span><span class="volume" tagx="volume" title="volume">57</span><span class="year" tagx="year" title="year">2013</span><span class="fpage" tagx="fpage" title="fpage">1743</span><span class="lpage" tagx="lpage" title="lpage">1755</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23357765">23357765</a></span></span></li> <li tag="ref"><a name="bib44" /><span class="label" tagx="label" title="label">44</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Elfiky</span><span class="given-names" tagx="given-names" title="given-names">A.A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Anti-HCV, nucleotide inhibitors, repurposing against COVID-19</span><span class="source" tagx="source" title="source">Life Sci</span><span class="volume" tagx="volume" title="volume">248</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">117477</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32119961">32119961</a></span></span></li> <li tag="ref"><a name="bib45" /><span class="label" tagx="label" title="label">45</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">HEP Drug interactions. 2020. Available from: <a href="https://www.hep-druginteractions.org/">https://www.hep-druginteractions.org/</a>. [Accessed 20 March 2020].</span></li> <li tag="ref"><a name="bib46" /><span class="label" tagx="label" title="label">46</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Richardson</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Griffin</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tucker</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Smith</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Oechsle</span><span class="given-names" tagx="given-names" title="given-names">O.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Phelan</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Baricitinib as potential treatment for 2019-nCoV acute respiratory disease</span><span class="source" tagx="source" title="source">Lancet</span><span class="volume" tagx="volume" title="volume">395</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">e30</span><span class="lpage" tagx="lpage" title="lpage">e31</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32032529">32032529</a></span></span></li> <li tag="ref"><a name="bib47" /><span class="label" tagx="label" title="label">47</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Markham</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Baricitinib: first global approval</span><span class="source" tagx="source" title="source">Drugs</span><span class="volume" tagx="volume" title="volume">77</span><span class="year" tagx="year" title="year">2017</span><span class="fpage" tagx="fpage" title="fpage">697</span><span class="lpage" tagx="lpage" title="lpage">704</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28290136">28290136</a></span></span></li> <li tag="ref"><a name="bib48" /><span class="label" tagx="label" title="label">48</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hoffmann</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kleine-Weber</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schroeder</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Krüger</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Herrler</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Erichsen</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor</span><span class="source" tagx="source" title="source">Cell</span><span class="year" tagx="year" title="year">2020</span></span></li> <li tag="ref"><a name="bib49" /><span class="label" tagx="label" title="label">49</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ramsey</span><span class="given-names" tagx="given-names" title="given-names">M.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nuttall</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hart</span><span class="given-names" tagx="given-names" title="given-names">P.A.</span></span><span class="collab'">collab: on behalf of the TIT</span></span><span class="mixed-article-title" title="mixed-article-title">A phase 1/2 trial to evaluate the pharmacokinetics, safety, and efficacy of NI-03 in patients with chronic pancreatitis: study protocol for a randomized controlled trial on the assessment of camostat treatment in chronic pancreatitis (TACTIC)</span><span class="source" tagx="source" title="source">Trials</span><span class="volume" tagx="volume" title="volume">20</span><span class="year" tagx="year" title="year">2019</span><span class="fpage" tagx="fpage" title="fpage">501</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31412955">31412955</a></span></span></li> <li tag="ref"><a name="bib50" /><span class="label" tagx="label" title="label">50</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">Press release on planned clinical trials to evaluate anakinra and emapalumab in COVID-19. 2020. Available from: <a href="https://www.sobi.com/en/press-releases/sobi-initiate-clinical-study-evaluate-whether-anakinra-and-emapalumab-may-relieve">https://www.sobi.com/en/press-releases/sobi-initiate-clinical-study-evaluate-whether-anakinra-and-emapalumab-may-relieve</a>. [Accessed 30 March 2020].</span></li> </ul> </div> <div class="supplementary-material" title="supplementary-material"> <div class="title" tagx="title" title="title">
Supplementary data</div> <p id="p0355"> </p><div class="local-data" title="local-data">  <div class="title" tagx="title" title="title">
Supplementary information</div>  <div class="media" title="media"><a href="mmc1.pdf">LINK</a></div> </div> <div class="local-data" title="local-data">  <div class="title" tagx="title" title="title">
disclosures.pdf</div>  <div class="media" title="media"><a href="mmc2.pdf">LINK</a></div> </div> <p /> </div> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
Acknowledgement</div> <p>We thank Benjamin Maasoumy for critically reviewing the manuscript and providing valuable comments.</p> </div> <div class="fn-group" title="fn-group"> <div class="fn-type-" title=""> <p id="ntpara0015">Author names in bold designate shared co-first authorship</p> </div> <div class="fn-type-supplementary-material" title="supplementary-material"> <p id="p0360">Supplementary data to this article can be found online at <a href="https://doi.org/10.1016/j.jhepr.2020.100113">https://doi.org/10.1016/j.jhepr.2020.100113</a>.</p> </div> </div> </div>  </body></html>